Where is Curiosis located?

Curiosis is headquartered in South Korea.

Who is the current CEO of Curiosis?

Hoyoung Yun of Curiosis. They have also founded 1 company.

How many employees does Curiosis have?

As of Jun 30, 2026, the latest employee count at Curiosis is 31.

Is Curiosis a funded company?

Curiosis is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Curiosis rank among its competitors?

Curiosis ranks 9th amongst 35 active competitors, of which 9 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was QCDx, which secured $5.3M in May, 2025.

Who are the top competitors of Curiosis?

Curiosis' top competitors include LUMICKS, Xcell Biosciences and Biolog. Among them, QCDx secured the most recent funding round in May, 2025.

Curiosis - 2026 Company Profile, Team, Funding & Competitors

Curiosis is a public company based in South Korea, founded in 2015 by Hoyoung Yun. It operates as a Developer of automation technologies for life science research laboratories. The company has 35 active competitors, including 9 funded and 4 that have exited. Its top competitors include companies like LUMICKS, Xcell Biosciences and Biolog.

Company Details

Developer of automation technologies for life science research laboratories. The flagship product Celloger Mini Plus is an automated live cell imaging system that enables real-time monitoring of cellular metabolism and behavior. It also offer a range of devices for cell counting, cell isolation,a nd digital pathology.

Website: curiosis.com
Social
Email ID: *****@curiosis.com, *****@curiosis.com
Phone Number: +82 **********

Key Metrics

Founded Year

2015

Location

South Korea

Stage

Public

Investors

Knet Investment Partners & 1 more

Ranked

9^th among 35 active competitors

Employee Count

31 as on Jun 30, 2026

Similar Companies

LUMICKS & 35 more

Exit Details

Public

View Curiosis' full profile

Curiosis got listed on Nov 13, 2025.

Click here to take a look at Curiosis's IPO in detail

Curiosis is a funded company. Curiosis has 2 institutional investors.

View details of Curiosis's funding rounds and investors

The founders of Curiosis is Hoyoung Yun. Hoyoung Yun is the CEO of Curiosis.

Here are the details of Curiosis' key team members:

Hoyoung Yun: Founder & CEO of Curiosis.

View details of Curiosis's Founder profiles and Board Members

Curiosis' employee count trend

Curiosis has 31 employees as of Jun 26. Here is Curiosis's employee count trend over the years:

Uncover Curiosis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Curiosis include LUMICKS, Xcell Biosciences and Biolog. Here is the list of Top 10 competitors of Curiosis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	LUMICKS 2014, Amsterdam (Netherlands), Series D	Manufacturer of optical tweezers for single molecule analysis instruments	$93.4M	Farallon Capital Management, Lauxera Capital Partners ... & 11 others	63/100
2nd	Xcell Biosciences 2012, San Francisco (United States), Series B	Developer of cell culture analysis device for cancer research	$40.9M	Casdin Capital, HBM Genomics & 10 others	59/100
3rd	Biolog 1984, Hayward (United States), Series A	Provider of cell-based phenotyping technologies and assays	$33.6M	Broadoak Capital Partners, RCT & 2 others	58/100
4th	IsoPlexis 2012, New Haven (United States), Acquired	Developer of multiplexed single-cell analysis tools for the diagnostics and life science research	$186M	Northpond Ventures, YEI Innovation Fund & 14 others	54/100
5th	Axion Biosystems 2007, Atlanta (United States), Acquired	Develops multi-electrode array technology to provide access to cellular information analysis	$20.3M	GRA Venture Fund, Georgia Research Alliance ... & 3 others	53/100
6th	LevitasBio 2017, San Francisco (United States), Series C	Developer of single-cell imaging and profiling platform based on magnetic levitation technology	$73.8M	Novalis LifeSciences, Decheng Capital & 1 others	49/100
7th	Lucid Scientific 2012, Atlanta (United States), Series A	Developer of real-time cell analysers	$13.4M	IAG Capital Partners, Dynamk Capital & 2 others	44/100
8th	ChemoMetec 1997, Alleroed (Denmark), Public	Automated cell counters and analyzers	-	Europa	43/100
9th	Curiosis 2015, South Korea, Public	Developer of automation technologies for life science research laboratories	-	Knet Investment Partners, Alpen Route	42/100
10th	QCDx 2016, Farmington (United States), Seed	Developer of instruments for the detection of rare cells in the blood circulation	$1.83M	Connecticut Innovations	32/100